Keith Katkin
individual
About
Keith Katkin is a biotechnology executive best known publicly for serving as CEO of Avanir Pharmaceuticals. Avanir was acquired by Otsuka Pharmaceutical in 2014 for $3.5 billion. The available evidence points to an operator in the biotech ecosystem rather than a fund manager or documented personal investor.
Areas of interest
biotechpharmaceuticalsneurologydrug development